Cancellation of state registration. Oxycourt®

November 20, 2017
Trade names:
ICD-10:
XII.L20-L30.L20.8    Other atopic dermatitis
XII.L20-L30.L21    Seborrheic dermatitis
XII.L20-L30.L23    Allergic contact dermatitis
XII.L20-L30.L24    Simple irritant contact dermatitis
XII.L20-L30.L28.0    Simple chronic lichen
XII.L40-L45.L40    Psoriasis
XII.L50-L54.L51.1    Bullous erythema multiforme
XII.L55-L59.L56.2    Photocontact dermatitis [berloque dermatitis]
XIX.T20-T32.T30    Thermal and chemical burns, unspecified
XIX.T33-T35.T33    Surface frostbite
Oxycorta, dermatitis, treatment of dermatitis, eczema, psiadiaz, treatment of psoriasis, burn, frostbite

The Ministry of Health of the Russian Federation in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N014899 / 01 from 29.05.2009 issued by LLC "VALEANT", Russia):

Oxycort® (trade name of the medicinal product)

Didrocortisone + oxytetracycline (international non-proprietary or grouping or chemical name)

ointment for external use, 10 mg + 30 mg / g (dosage form, dosage)

Pharmaceutical plant Elfa AO, Poland ul. Wincentego Pola 21, 58-500 Jelenia Gora, Poland (name and address of the location of the manufacturer of the medicinal product)

on the basis of the filing of an application for the abolition of the state registration of a medicinal product by the authorized legal entity LLC "VALEANT", Russia.